Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

BUY
$14.37 - $16.46 $376,494 - $431,252
26,200 New
26,200 $426,000
Q3 2023

Nov 14, 2023

SELL
$9.81 - $12.62 $42,183 - $54,266
-4,300 Reduced 17.41%
20,400 $229,000
Q2 2023

Aug 14, 2023

SELL
$8.08 - $10.37 $309,464 - $397,170
-38,300 Reduced 60.79%
24,700 $248,000
Q1 2023

May 15, 2023

BUY
$8.79 - $14.58 $311,165 - $516,132
35,400 Added 128.26%
63,000 $592,000
Q4 2022

Feb 14, 2023

SELL
$11.49 - $13.65 $267,717 - $318,045
-23,300 Reduced 45.78%
27,600 $337,000
Q3 2022

Nov 14, 2022

BUY
$12.41 - $32.42 $631,669 - $1.65 Million
50,900 New
50,900 $632,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.7B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.